Failed study of bumetanide in Autism: limitations of the Dutch trial and what does it means for bumetanide treatment
Bruining and colleagues reported, in a 3-month mono-centric trial in 92 verbal ASD children (7-15 years old) without severe mental disability, that bumetanide did not significantly attenuate the severity of autism. This trial is at odds with 5 earlier trials from 3 independent groups who reported significant ameliorations. Astonishingly, the same group reported earlier that … Read more
